The anti-cancer effect of BRAF inhibitors was also studied in a orthotopic mouse model of anaplastic thyroid carcinoma, which had been obtained by injecting a thyroid cancer cell line in mice with severe combined immunodeficiency [74]. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.